The Effect of Erigeron Injection on Acute Cerebral Infarction Serum VEGF, MMP-9 and EPC Levels

• Status: Unknown status
• Trial end date: 2014-03-01
• Target enrollment: 0
• Participant gender: All

Summary

To study the effects of Erigeron Injection on human serum VEGF, MMP-9 and EPC levels after acute cerebral infarction,test is made by random double-blind controlled.patients with acute cerebral infarction were divided randomly into erigeron injection+aspirin group,aspirin group,and health people. The main indexes are the serum level of VEGF, MMP-9 and EPC.The review is made by the reference to NIHSS and so on. So, Erigeron Injection have the function of promoting angiogenesis in multiple targets through this test.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Guangzhou University of Traditional Chinese Medicine

Criteria

Inclusion Criteria:

• patients aged no younger than 18yrs

• attack within 72 hours

• NIHSS score in the 2-25 points

• Ischemic Stroke occurred for the first time, or with a history of stroke disease but without sequelae

• Signed the informed consents

Exclusion Criteria:

• patients aged younger than 18yrs

• Patients with tumor, coronary heart disease, valvular heart disease, psoriasis, rheumatism, hematologic diseases, infertility, varieties of acute inflammation

• Patients with severe cognitive impairment

• Refused to cooperate or been unable to cooperation for neurological disorders

• Cerebral hemorrhage or hemorrhagic cerebral infarction

• Unstable vital signs dued to massive cerebral infarction

• Patients with serious heart, liver and renal insufficiency